Global Blood Glucose Testing Market Report (2025–2036)
Market Overview
The global blood glucose testing market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Rising prevalence of diabetes, increasing awareness of preventive healthcare, and technological advancements in portable and continuous monitoring devices are driving market growth. The market is shifting from traditional desktop devices to portable, connected, and wearable solutions.
Impact of COVID-19
The pandemic disrupted supply chains and delayed routine healthcare visits in 2020. However, demand for blood glucose testing devices surged as patients sought home-based monitoring solutions. Post-pandemic, telemedicine and digital health integration have accelerated adoption of portable and connected glucose monitoring systems.
Segmentation Analysis
By Type
· Desktop Devices
· Portable Devices
· Continuous Glucose Monitoring (CGM) Systems
· Smart Connected Devices (Bluetooth/Wi-Fi enabled)
· Others
By Application
· Hyperglycemia (High Blood Glucose)
· Tight Diabetes Control
· Hypoglycemia Monitoring
· Preventive Health Screening
· Others
By End User
· Hospitals
· Clinics
· Pharmacies & Retail Drugstores
· Homecare Settings
· Diagnostic Laboratories
Regional Analysis
· North America: Leading market due to high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of CGM devices.
· Europe: Growth supported by government-funded healthcare programs and widespread adoption of portable monitoring solutions.
· Asia-Pacific: Fastest-growing region, driven by rising diabetes cases in India and China, expanding healthcare systems, and increasing awareness of preventive care.
· South America: Moderate growth, with Brazil leading in diabetes care expansion.
· Middle East & Africa: Emerging opportunities with increasing healthcare investments and rising demand for affordable monitoring devices.
Key Players
· Abbott Laboratories
· Bayer AG
· Bio-Rad Laboratories Inc.
· Menarini Diagnostics
· Acon Laboratories Inc.
· AgaMatrix Inc.
· Roche Diagnostics
· Ascensia Diabetes Care
· Dexcom Inc.
· Medtronic Plc
· Lifescan Inc. (Johnson & Johnson)
· Terumo Corporation
· Nipro Corporation
· B. Braun Melsungen AG
Porter’s Five Forces
· Threat of New Entrants: Moderate, due to regulatory requirements and R&D costs.
· Bargaining Power of Suppliers: Moderate, with reliance on specialized sensors and reagents.
· Bargaining Power of Buyers: High, as patients and healthcare providers demand affordable yet accurate devices.
· Threat of Substitutes: Moderate, with alternatives like non-invasive monitoring technologies.
· Industry Rivalry: High, with global and regional players competing on innovation, connectivity, and pricing.
SWOT Analysis
Strengths: Essential for diabetes management, strong demand across demographics. Weaknesses: High device costs, limited access in low-income regions. Opportunities: Growth in connected and wearable devices, expansion in emerging markets. Threats: Regulatory hurdles, counterfeit products, competition from non-invasive technologies.
Trend Analysis
· Rising demand for continuous glucose monitoring (CGM) systems.
· Increasing adoption of smart connected devices integrated with mobile apps.
· Growth in telemedicine and remote patient monitoring.
· Expansion of eco-friendly and reusable testing solutions.
Drivers & Challenges
Drivers:
· Rising global prevalence of diabetes.
· Increasing awareness of preventive healthcare.
· Technological advancements in portable and connected devices.
Challenges:
· High costs limiting accessibility.
· Regulatory compliance requirements.
· Limited awareness in developing regions.
Value Chain Analysis
· Raw Material Suppliers (sensors, reagents, electronics) → Manufacturers → Distributors/Retailers → Hospitals/Clinics/Consumers
· Integration of IoT and AI is reshaping the value chain, improving device efficiency and patient outcomes.
Recommendations for Stakeholders
· Manufacturers: Invest in connected, wearable, and non-invasive glucose monitoring technologies.
· Healthcare Providers: Promote adoption of CGM systems for better patient outcomes.
· Investors: Focus on Asia-Pacific for high growth potential.
· Policy Makers: Support affordable diabetes care initiatives and strengthen regulatory frameworks for safety.
1. Market Overview of Blood Glucose Testing
1.1 Blood Glucose Testing Market Overview
1.1.1 Blood Glucose Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Blood Glucose Testing Market Size by Regions:
1.3 Blood Glucose Testing Historic Market Size by Regions
1.4 Blood Glucose Testing Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Blood Glucose Testing Sales Market by Type
2.1 Global Blood Glucose Testing Historic Market Size by Type
2.2 Global Blood Glucose Testing Forecasted Market Size by Type
2.3 Desktop Device
2.4 Portable Device
2.5 Others
3. Covid-19 Impact Blood Glucose Testing Sales Market by Application
3.1 Global Blood Glucose Testing Historic Market Size by Application
3.2 Global Blood Glucose Testing Forecasted Market Size by Application
3.3 Hyperglycemia (High Blood Glucose)
3.4 Tight Diabetes Control
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Blood Glucose Testing Production Capacity Market Share by Manufacturers
4.2 Global Blood Glucose Testing Revenue Market Share by Manufacturers
4.3 Global Blood Glucose Testing Average Price by Manufacturers
5. Company Profiles and Key Figures in Blood Glucose Testing Business
5.1 American Diabetes Association
5.1.1 American Diabetes Association Company Profile
5.1.2 American Diabetes Association Blood Glucose Testing Product Specification
5.1.3 American Diabetes Association Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.2 Diabetes
5.2.1 Diabetes Company Profile
5.2.2 Diabetes Blood Glucose Testing Product Specification
5.2.3 Diabetes Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.3 Menarini Diagnostics
5.3.1 Menarini Diagnostics Company Profile
5.3.2 Menarini Diagnostics Blood Glucose Testing Product Specification
5.3.3 Menarini Diagnostics Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.4 Abaxis
5.4.1 Abaxis Company Profile
5.4.2 Abaxis Blood Glucose Testing Product Specification
5.4.3 Abaxis Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.5 Abbott
5.5.1 Abbott Company Profile
5.5.2 Abbott Blood Glucose Testing Product Specification
5.5.3 Abbott Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.6 Acon
5.6.1 Acon Company Profile
5.6.2 Acon Blood Glucose Testing Product Specification
5.6.3 Acon Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.7 AgaMatrix
5.7.1 AgaMatrix Company Profile
5.7.2 AgaMatrix Blood Glucose Testing Product Specification
5.7.3 AgaMatrix Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.8 Bayer
5.8.1 Bayer Company Profile
5.8.2 Bayer Blood Glucose Testing Product Specification
5.8.3 Bayer Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
5.9 Bio-Rad
5.9.1 Bio-Rad Company Profile
5.9.2 Bio-Rad Blood Glucose Testing Product Specification
5.9.3 Bio-Rad Blood Glucose Testing Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Blood Glucose Testing Market Size
6.2 North America Blood Glucose Testing Key Players in North America
6.3 North America Blood Glucose Testing Market Size by Type
6.4 North America Blood Glucose Testing Market Size by Application
7. East Asia
7.1 East Asia Blood Glucose Testing Market Size
7.2 East Asia Blood Glucose Testing Key Players in North America
7.3 East Asia Blood Glucose Testing Market Size by Type
7.4 East Asia Blood Glucose Testing Market Size by Application
8. Europe
8.1 Europe Blood Glucose Testing Market Size
8.2 Europe Blood Glucose Testing Key Players in North America
8.3 Europe Blood Glucose Testing Market Size by Type
8.4 Europe Blood Glucose Testing Market Size by Application
9. South Asia
9.1 South Asia Blood Glucose Testing Market Size
9.2 South Asia Blood Glucose Testing Key Players in North America
9.3 South Asia Blood Glucose Testing Market Size by Type
9.4 South Asia Blood Glucose Testing Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Blood Glucose Testing Market Size
10.2 Southeast Asia Blood Glucose Testing Key Players in North America
10.3 Southeast Asia Blood Glucose Testing Market Size by Type
10.4 Southeast Asia Blood Glucose Testing Market Size by Application
11. Middle East
11.1 Middle East Blood Glucose Testing Market Size
11.2 Middle East Blood Glucose Testing Key Players in North America
11.3 Middle East Blood Glucose Testing Market Size by Type
11.4 Middle East Blood Glucose Testing Market Size by Application
12. Africa
12.1 Africa Blood Glucose Testing Market Size
12.2 Africa Blood Glucose Testing Key Players in North America
12.3 Africa Blood Glucose Testing Market Size by Type
12.4 Africa Blood Glucose Testing Market Size by Application
13. Oceania
13.1 Oceania Blood Glucose Testing Market Size
13.2 Oceania Blood Glucose Testing Key Players in North America
13.3 Oceania Blood Glucose Testing Market Size by Type
13.4 Oceania Blood Glucose Testing Market Size by Application
14. South America
14.1 South America Blood Glucose Testing Market Size
14.2 South America Blood Glucose Testing Key Players in North America
14.3 South America Blood Glucose Testing Market Size by Type
14.4 South America Blood Glucose Testing Market Size by Application
15. Rest of the World
15.1 Rest of the World Blood Glucose Testing Market Size
15.2 Rest of the World Blood Glucose Testing Key Players in North America
15.3 Rest of the World Blood Glucose Testing Market Size by Type
15.4 Rest of the World Blood Glucose Testing Market Size by Application
16 Blood Glucose Testing Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segmentation Analysis
By Type
· Desktop Devices
· Portable Devices
· Continuous Glucose Monitoring (CGM) Systems
· Smart Connected Devices (Bluetooth/Wi-Fi enabled)
· Others
By Application
· Hyperglycemia (High Blood Glucose)
· Tight Diabetes Control
· Hypoglycemia Monitoring
· Preventive Health Screening
· Others
By End User
· Hospitals
· Clinics
· Pharmacies & Retail Drugstores
· Homecare Settings
· Diagnostic Laboratories
Regional Analysis
· North America: Leading market due to high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of CGM devices.
· Europe: Growth supported by government-funded healthcare programs and widespread adoption of portable monitoring solutions.
· Asia-Pacific: Fastest-growing region, driven by rising diabetes cases in India and China, expanding healthcare systems, and increasing awareness of preventive care.
· South America: Moderate growth, with Brazil leading in diabetes care expansion.
· Middle East & Africa: Emerging opportunities with increasing healthcare investments and rising demand for affordable monitoring devices.
Key Players
· Abbott Laboratories
· Bayer AG
· Bio-Rad Laboratories Inc.
· Menarini Diagnostics
· Acon Laboratories Inc.
· AgaMatrix Inc.
· Roche Diagnostics
· Ascensia Diabetes Care
· Dexcom Inc.
· Medtronic Plc
· Lifescan Inc. (Johnson & Johnson)
· Terumo Corporation
· Nipro Corporation
· B. Braun Melsungen AG
